Showing results (231-240 of 9,399) with videos related to

Sort By:
Pageof 940
Clinical Pharmacology and Therapeutics|August 7, 2023
Concurrent Gabapentin and Opioid Use and Risk of Mortality in Medicare Recipients with Non-Cancer PainMeghan A Corriere, Laura L Daniel, Alyson L Dickson, et al.
Clinical Pharmacology and Therapeutics|August 22, 2023
CYP2C19 Loss-of-Function Variants Associated With Long-Term Ischemic Stroke Events During Clopidogrel Treatment in the Chinese PopulationPeng Wu, Ziqing Liu, Zijian Tian, et al.
Clinical Pharmacology and Therapeutics|August 19, 2023
Patient Centric Microsampling to Support Paxlovid Clinical Development: Bridging and ImplementationKatty Wan, Olga Kavetska, Bharat Damle, et al.
Clinical Pharmacology and Therapeutics|August 1, 2023
Impact of CYP2C:TG Haplotype on CYP2C19 Substrates Clearance In Vivo, Protein Content, and In Vitro ActivityPablo Zubiaur, Paula Soria-Chacartegui, Erin C Boone, et al.
Clinical Pharmacology and Therapeutics|October 19, 2023
High-Dose vs. Standard-Dose Influenza Vaccine and Cardiopulmonary Hospitalization or Mortality: Emulating the INVESTED Trial Using Insurance Claims DataMehdi NajafZadeh, HoJin Shin, Sebastian Schneeweiss, et al.
Clinical Pharmacology and Therapeutics|October 13, 2023
Machine Learning-Based Quantification of Patient Factors Impacting Remission in Patients With Ulcerative Colitis: Insights from Etrolizumab Phase III Clinical TrialsRashed Harun, James Lu, Nastya Kassir, et al.
Clinical Pharmacology and Therapeutics|October 27, 2023
Rescuing Drugs That are Discontinued in Adult Oncology Development for the Benefit of Children and Adolescents With Cancer - An ACCELERATE Multistakeholder ConsensusTeresa de Rojas, Davy Chiodin, Andrew D J Pearson, et al.
Clinical Pharmacology and Therapeutics|October 1, 2023
Population Pharmacokinetics and Exposure-Response Analysis for the CTLA-4 Inhibitor Tremelimumab in Metastatic NSCLC Patients in the Phase III POSEIDON StudyJimmy Zhijian He, Vincent Duval, Petra Jauslin, et al.
Clinical Pharmacology and Therapeutics|July 1, 2023
Digital Therapeutics as a New Therapeutic Modality: A Review from the Perspective of Clinical PharmacologyBenjamin Ribba, Richard Peck, Lucy Hutchinson, et al.
Clinical Pharmacology and Therapeutics|July 2, 2023
Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR-T and TCR-T Cell Therapies: An Industry PerspectiveHardik Mody, Ken Ogasawara, Xu Zhu, et al.
Pageof 940